title: Breast cancer in 2013: Genomics, drug approval, and optimal treatment duration.
authors.affiliation: Departments of Pharmacology and Chemical Biology, Human Genetics, and Medicine, Women's Cancer Research Center, Magee-Womens Research Institute, University of Pittsburgh, 204 Craft Avenue, Pittsburgh, PA 15238, USA.
authors.forename: Adrian V
authors.initials: AV
authors.lastname: Lee
authors.affiliation: University of Pittsburgh Cancer Institute and University of Pittsburgh Medical Center Cancer Center, 5150 Center Avenue, Pittsburgh, PA 15232, USA.
authors.forename: Nancy E
authors.initials: NE
authors.lastname: Davidson
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000235:genetics*; D017277:Drug Approval; D005260:Female; D023281:Genomics; D057166:High-Throughput Screening Assays; D006801:Humans; D013997:Time Factors
chemical_list: D000970:Antineoplastic Agents